@dr.amromahmoud
1 post audited · 4 claims analysed
Science evidence grade
Based on 4 claims across 1 audit
3
Supported
75%
0
Overstated
0%
0
Misleading
0%
1
No Evidence
25%
Share this evidence grade
Claim-level evidence grades — not a character judgment. Methodology · Right of reply · Leaderboards
What @dr.amromahmoud claims actually are
We separate claims into three buckets: backed by evidence, factually incorrect, and grey — like animal-only findings sold as human fact (e.g. BPC-157 “fixes Achilles” from rat studies).
Evidence-based
75%
3 claims
Claims that align with published human or clinical evidence at the stated strength.
Ex: “Semaglutide can reduce body weight in adults with obesity” — supported by large RCTs.
Factually incorrect
0%
0 claims
Claims that conflict with the evidence, invent certainty, or omit critical safety/context in a misleading way.
Ex: “Peptides have no side effects” — contradicts known adverse-event profiles.
Grey / overstated
25%
1 claim
Plausible direction but wrong certainty — animal-only data sold as human fact, dose/effect overstated, or no adequate published support yet.
Ex: “BPC-157 fixes Achilles tears” — often rests on rodent tendon models, not proven human Achilles repair trials.
Evidence mix
Share of audited claims in each bucket
Verdict detail
Grey splits into overstated (wrong certainty) vs no published support
Claims over time
Stacked by bucket as audits land — plus the running evidence grade
Gold line = running science evidence grade (Supported + ½ Overstated ÷ total claims).
Audit history(1 post)
“What is BPC-157 and why are people using it for injury recovery, gut health, and inflammation? This peptide is derived from gastric proteins and shows promise in tissue regeneration. Most use 250-500 mcg daily for 4-6 weeks. But here’s the catch—it’s not FDA approved and is now being banned from compounding pharmacies. There’s also a new alternative: PetiDeca-Arginate (PDA-1). Learn the facts before you try it. #BPC157 #PeptideTherapy #HealingPeptide #InjuryRecovery #TissueRepair #GutHealth #LongevityMedicine #FunctionalMedicine #Biohacking101 #PeptidesExplained #PDA1 #PeptideStack #DoctorExplains #FDAWarning #BPCBan #RegenerativeMedicine”
BPC-157's use for injury recovery and tissue regeneration is supported by robust preclinical evidence (35+ animal studies with consistent positive outcomes) and a Phase 2 human RCT currently recruiting. A 2025 systematic review and multiple mechanism-focused studies document BPC-157's effects on growth factor pathways and angiogenesis. However, claims about gut health and inflammation lack direct supporting evidence in the retrieved literature. Human clinical data remain limited (one retrospective study of 12 patients, three pilot studies total), so claims should emphasize that benefits are primarily preclinically validated and that regulatory status (not FDA-approved, banned in professional sports) should inform clinical decision-making.
Audit another post from @dr.amromahmoud
Paste their social post link to add a new audit